Published in Cancer Weekly, July 12th, 1999
D. Avigan and colleagues, Harvard Medical School, Boston, Massachusetts, are completing a study examining the nature of humoral and cellular immune reconstitution in patients with advanced breast cancer who have undergone high-dose chemotherapy with stem cell rescue.
They reported on their study at the 35th annual meeting of the American Society of Clinical Oncology (ASCO) May 15-18, 1999, held in Atlanta, Georgia ("Immune Reconstitution Following High Dose Chemotherapy with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.